Acute-phase Serum Cytokine Levels and Correlation with Clinical Outcomes in Children and Adults with Primary and Secondary Dengue Virus Infection in Myanmar between 2017 and 2019
Authors:
- Khine Mya NweKNKhine Mya Nwe
- Mya Myat Ngwe TunMTMya Myat Ngwe Tun
- Theingi Win MyatTMTheingi Win Myat
- Chris Fook Sheng NgCNChris Fook Sheng Ng
- Moh Moh HtunMHMoh Moh Htun
- Htin LinHLHtin Lin
- Nang Sarm HomNHNang Sarm Hom
- Aung Min SoeASAung Min Soe
- Annie Elong NgonoANAnnie Elong Ngono
- Shinjiro HamanoShinjiro Hamano
- Kouichi MoritaKMKouichi Morita
- Kyaw Zin ThantKTKyaw Zin Thant
Open Access
Abstract
The dengue virus (DENV) has been endemic in Myanmar since 1970, causing outbreaks every 2–3 years. DENV infection symptoms range from mild fever to lethal hemorrhage. Clinical biomarkers must be identified to facilitate patient risk stratification in the early stages of infection. We analyzed 45 cytokines and other factors in serum samples from the acute phase of DENV infection (within 3–5 days of symptom onset) from 167 patients in Yangon, Myanmar, between 2017 and 2019. All of the patients tested positive for serum DENV nonstructural protein 1 antigen (NS1 Ag); 78.4% and 62.9% were positive for immunoglobulin M (IgM) and G (IgG), respectively; and 18.0%, 19.8%, and 11.9% tested positive for serotypes 1, 3, and 4, respectively. Although the DENV-4 viral load was significantly higher than those of DENV-1 or DENV-3, disease severity was not associated with viral load or serotype. Significant correlations were identified between disease severity and CCL5, SCF, PDGF-BB, IL-10, and TNF-α levels; between NS1 Ag and SCF, CCL5, IFN-α, IL-1α, and IL-22 levels; between thrombocytopenia and IL-2, TNF-α, VEGF-D, and IL-6 levels; and between primary or secondary infection and IL-2, IL-6, IL-31, IL-12p70, and MIP-1β levels. These circulating factors may represent leading signatures in acute DENV infections, reflecting the clinical outcomes in the dengue endemic region, Myanmar.Keywords
Funding Information
- Japan Agency for Medical Research and Development (AMED) (19jm0210047h0004, 21fk0108109h9903, 21wm0225018h0002, 21fk0108123h1602, JP21wm0125006)
- AMED Research on Emerging and Re-emerging Infectious Diseases (19jm0210047h0004, 21fk0108109h9903, 21wm0225018h0002, 21fk0108123h1602, JP21wm0125006)
- Japan Program for Infectious Diseases Research and Infrastructure (19jm0210047h0004, 21fk0108109h9903, 21wm0225018h0002, 21fk0108123h1602, JP21wm0125006)
- Nagasaki University (19jm0210047h0004, 21fk0108109h9903, 21wm0225018h0002, 21fk0108123h1602, JP21wm0125006)
This publication has 48 references indexed in Scilit:
- An emerging role for the anti-inflammatory cytokine interleukin-10 in dengue virus infectionJournal of Biomedical Science, 2013
- Alteration of Cytokines and Chemokines During Febrile Episodes Associated With Endothelial Cell Damage and Plasma Leakage in Dengue Hemorrhagic FeverThe Pediatric Infectious Disease Journal, 2012
- Serum Proteome and Cytokine Analysis in a Longitudinal Cohort of Adults with Primary Dengue Infection Reveals Predictive Markers of DHFPLOS Neglected Tropical Diseases, 2012
- Refining the Global Spatial Limits of Dengue Virus Transmission by Evidence-Based ConsensusPLOS Neglected Tropical Diseases, 2012
- Kinetics of Plasma Viremia and Soluble Nonstructural Protein 1 Concentrations in Dengue: Differential Effects According to Serotype and Immune StatusThe Journal of Infectious Diseases, 2011
- Evaluation of a Dengue IgG Indirect Enzyme-Linked Immunosorbent Assay and a Japanese Encephalitis IgG Indirect Enzyme-Linked Immunosorbent Assay for Diagnosis of Secondary Dengue Virus InfectionVector-Borne and Zoonotic Diseases, 2009
- Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severityBMC Infectious Diseases, 2008
- Development and Evaluation of Fluorogenic TaqMan Reverse Transcriptase PCR Assays for Detection of Dengue Virus Types 1 to 4Journal of Clinical Microbiology, 2004
- High Circulating Levels of the Dengue Virus Nonstructural Protein NS1 Early in Dengue Illness Correlate with the Development of Dengue Hemorrhagic FeverThe Journal of Infectious Diseases, 2002
- Antibody-capture ELISA for detection of immunoglobulin M antibodies in sera from japanese encephalitis and dengue hemorrhagic fever patientsJournal of Virological Methods, 1985